Keros Therapeutics (KROS) Price to Sales (2020 - 2026)
Keros Therapeutics' (KROS) Price to Sales stood at 6.47 in Q2 2026, up 177.6% from 2.33 a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Price to Sales (2020 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics' Price to Sales came in at 3.11, down 98.3% from FY2024.
- Across earlier years, Price to Sales came in at 180.84 in FY2024 (-97.8%), 8384.12 in FY2023 and 69.79 in FY2021.
- The Q2 2026 figure is the highest quarterly Price to Sales since Q4 2024.
- On a year-over-year basis, Price to Sales rose in 1 of the last seven quarters, with an average decline of 59.3%.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 177.6% in Q2 2026, against a decline of 100.0% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.21 Bn | 1,108.80 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 632.33 Bn | 552.19 Bn | 17.30 Bn |
| 3 | AbbVie | 500.02 Bn | 473.13 Bn | 12.70 Bn |
| 4 | Merck | 355.31 Bn | 309.69 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.67 Bn | 264.66 Bn | 11.24 Bn |
| 6 | Astrazeneca | 263.56 Bn | 237.25 Bn | 12.86 Bn |
| 7 | Amgen | 237.81 Bn | 193.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.42 Bn | 168.61 Bn | 6.22 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn |
| 10 | Keros Therapeutics | 218.00 Mn | -1.71 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.47 |
| Dec 31, 2025 | 3.11 |
| Sep 30, 2025 | 2.61 |
| Jun 30, 2025 | 2.33 |
| Mar 31, 2025 | 1.93 |
| Dec 31, 2024 | 180.84 |
| Sep 30, 2024 | 3,501.90 |
| Jun 30, 2024 | 6,099.44 |
| Mar 31, 2024 | 10,203.79 |
| Dec 31, 2023 | 8,384.12 |
| Sep 30, 2023 | 118,271.38 |
| Dec 31, 2022 | 73.48 |
| Sep 30, 2022 | 25.82 |
| Jun 30, 2022 | 17.76 |
| Mar 31, 2022 | 34.26 |
| Dec 31, 2021 | 69.79 |
| Sep 30, 2021 | 9,255.77 |
| Jun 30, 2021 | 9,907.73 |
| Sep 30, 2020 | 311.43 |
| Jun 30, 2020 | 151.23 |
API Access
Keros Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();